Zurueck zur Suche

Reporte zur Charge 9R4N2

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
PR 1

VAERS 2726471

UNKNOWN MANUFACTURER · ZOSTER (NO BRAND NAME) · Charge 9R4N2

mild
Staat
PR
Alter
-
Geschlecht
U
Eingang
21.12.2023
Impfdatum
-
Beginn
15.08.2022
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Immunisation reaction Inappropriate schedule of product administration Pruritus Ulcer

Symptomtext

Multiple small ulcers with itch; Itch; The 2nd dose of shingles (8/15/22); This non-serious case was reported by a other health professional via call center representative and described the occurrence of ulcer in a patient who received Herpes zoster (Shingles vaccine) (batch number 3BD53, expiry date 07-JUL-2023) and (batch number 9R4N2, expiry date 07-JUL-2023) for prophylaxis. Previously administered products included Shingrix (on 06-APR-2018, the patient received 1st dose). On 15-AUG-2022, the patient received the 2nd dose of Shingles vaccine. On 15-AUG-2022, an unknown time after receiving Shingles vaccine, the patient experienced drug dose administration interval too long (Verbatim: The 2nd dose of shingles (8/15/22)). On an unknown date, the patient experienced ulcer (Verbatim: Multiple small ulcers with itch) and pruritus (Verbatim: Itch). The outcome of the ulcer and pruritus were not resolved and the outcome of the drug dose administration interval too long was unknown. The reporter considered the ulcer and pruritus to be related to Shingles vaccine. The company considered the ulcer and pruritus to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 11-DEC-2023 The reporter was a Risk Control Coordinator. The patient received 2nd dose of Shingles that caused multiple small ulcers with itch, that was everyday worst. The reporter requested copy of medication insert / literature on the shingles vaccine and to confirm if there were any re-calls to this specific lot. The patient received the 2nd dose of Shingles vaccine later than recommended interval, which led to lengthening of vaccination schedule.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2525169

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9r4n2

gering
Staat
-
Alter
97,0
Geschlecht
M
Eingang
07.12.2022
Impfdatum
02.08.2022
Beginn
03.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2482722

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge 9r4n2

gering
Staat
-
Alter
65,0
Geschlecht
M
Eingang
18.10.2022
Impfdatum
16.08.2022
Beginn
07.09.2022
Tage bis Beginn
22,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Unevaluable event

Symptomtext

Narrative: ED visit only

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-